Skip to content
Recall Observatory FDA recall evidence

Drug product

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

D-0213-2025

January 17, 2025

Class II

Product summary

Firm
McKesson
Event
Event 96167
Status
Ongoing
Classification
Class II
Quantity
192 vials
Official record key
drug-enforcement:D-0213-2025

Official wording

Reason: cGMP Deviations: Product intended for quarantine was inadvertently distributed.

Code information: Lot# 04647349, Exp Date 5/31/2029

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations